The Soy Isoflavones for Reducing Bone Loss (SIRBL) Study: a 3-y randomized controlled trial in postmenopausal women

被引:107
|
作者
Alekel, D. Lee [1 ]
Van Loan, Marta D.
Koehler, Kenneth J. [2 ]
Hanson, Laura N. [1 ]
Stewart, Jeanne W. [1 ]
Hanson, Kathy B. [1 ]
Kurzer, Mindy S. [3 ]
Peterson, C. Theodore [2 ]
机构
[1] Iowa State Univ, Nutr & Wellness Res Ctr, Dept Food Sci & Human Nutr, Ames, IA 50010 USA
[2] Iowa State Univ, Dept Stat, Ames, IA 50010 USA
[3] Univ Calif Davis, USDA, Agr Res Serv, Western Human Nutr Res Ctr, Davis, CA 95616 USA
来源
关键词
ESTROGEN PLUS PROGESTIN; MINERAL DENSITY; DOUBLE-BLIND; PROTEIN ISOLATE; MENOPAUSAL SYMPTOMS; SERUM-LIPIDS; RISK; MASS; CONSUMPTION; CALCIUM;
D O I
10.3945/ajcn.2009.28306
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Our previous study indicated that soy protein with isoflavones lessened lumbar spine bone loss in midlife women. Objective: We examined the efficacy of isoflavones (extracted from soy protein) on bone mineral density (BMD) in nonosteoporotic postmenopausal women. We hypothesized that isoflavone tablets would spare BMD, with biological (age, body weight, serum 25-hydroxyvitamin D) and lifestyle (physical activity, dietary intake) factors modulating BMD loss. Design: Our double-blind, randomized controlled trial (36 mo) included healthy postmenopausal women (aged 45.8-65.0 y) with intent-to-treat (n = 224) and compliant (n = 208) analyses. Treatment groups consisted of a placebo control group and 2 soy isoflavone groups (80 compared with 120 mg/d); women received 500 mg calcium and 600 IU vitamin D3. Outcomes included lumbar spine, total proximal femur, femoral neck, and whole-body BMD. Results: Analysis of variance for intent-to-treat and compliant (>= 80%) models, respectively, showed no treatment effect for spine (P = 0.46, P = 0.21), femur (P = 0.86, P = 0.46), neck (P = 0.17, P = 0.14), or whole-body (P = 0.86, P = 0.78) BMD. From baseline to 36 mo, BMD declined regardless of treatment. In intent-to-treat and compliant models, respectively, BMD decreases were as follows: spine (-2.08%, -1.99%), femur (-1.43%, -1.38%), neck (-2.56%, -2.51%), and whole body (-1.66%, -1.62%). Regression analysis (compliant model) indicated that age, whole-body fat mass, and bone resorption were common predictors of BMD change. After adjustment for these factors, 120 mg (compared with placebo) was protective (P = 0.024) for neck BMD. We observed no treatment effect on adverse events, endometrial thickness, or bone markers. Conclusion: Our results do not show a bone-sparing effect of extracted soy isoflavones, except for a modest effect at the femoral neck. This trial was registered at clinicaltrials.gov as NCT00043745. Am J Clin Nutr 2010;91:218-30.
引用
收藏
页码:218 / 230
页数:13
相关论文
共 50 条
  • [1] Soy Isoflavones for Reducing Bone Loss (SIRBL) Study: Effect of a three-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women
    Alekel, D. Lee
    Genschel, Ulrike
    Koehler, Kenneth J.
    Hofmann, Heike
    Van Loan, Marta D.
    Beer, Bonnie S.
    Hanson, Laura N.
    Peterson, Charles T.
    Kurzer, Mindy S.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (12): : 1328 - 1329
  • [2] Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women
    Alekel, D. Lee
    Genschel, Ulrike
    Koehler, Kenneth J.
    Hofmann, Heike
    Van Loan, Marta D.
    Beer, Bonnie S.
    Hanson, Laura N.
    Peterson, Charles T.
    Kurzer, Mindy S.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (02): : 185 - 197
  • [3] Soy isoflavones attenuate bone loss in early postmenopausal Chinese women - A single-blind randomized, placebo-controlled trial
    Ye, Yan-Bin
    Tang, Xing-Yi
    Verbruggen, Marian A.
    Su, Yi-Xiang
    EUROPEAN JOURNAL OF NUTRITION, 2006, 45 (06) : 327 - 334
  • [4] Soy protein containing isoflavones and mammographic density in a randomized controlled trial in postmenopausal women
    Verheus, Martijn
    van Gils, Carla H.
    Kreijkamp-Kaspers, Sanne
    Kok, Linda
    Peeters, Petra H. M.
    Grobbee, Diederick E.
    van der Schouw, Yvonne T.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (10) : 2632 - 2638
  • [5] Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: A double-blind, randomized, controlled trial
    Chen, YM
    Ho, SC
    Lam, SSH
    Ho, SSS
    Woo, JLF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10): : 4740 - 4747
  • [6] The Soy Isoflavones for Reducing Bone Loss Study: 3-Yr Effects on pQCT Bone Mineral Density and Strength Measures in Postmenopausal Women
    Shedd-Wise, Kristine M.
    Alekel, D. Lee
    Hofmann, Heike
    Hanson, Kathy B.
    Schiferl, Dan J.
    Hanson, Laura N.
    Van Loan, Marta D.
    JOURNAL OF CLINICAL DENSITOMETRY, 2011, 14 (01) : 47 - 57
  • [7] Isolated soy isoflavones prevent bone loss in the hip in postmenopausal women
    Vincent, A
    Fitzpatrick, LA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S371 - S371
  • [8] A randomized controlled trial on the effects of soy protein containing isoflavones on vascular function in postmenopausal women
    Kreijkamp-Kaspers, S
    Kok, L
    Bots, ML
    Lampe, JW
    Van Der Schouw, YT
    Grobbee, DE
    JOURNAL OF HYPERTENSION, 2004, 22 : S255 - S255
  • [9] Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women
    Kreijkamp-Kaspers, S
    Kok, L
    Bots, ML
    Grobbee, DE
    Lampe, JW
    van der Schouw, YT
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 81 (01): : 189 - 195
  • [10] The Role of Soy Isoflavones in the Prevention of Bone Loss in Postmenopausal Women: A Systematic Review with Meta-Analysis of Randomized Controlled Trials
    Baranska, Agnieszka
    Kanadys, Wieslaw
    Bogdan, Magdalena
    Stepien, Ewa
    Barczynski, Bartlomiej
    Klak, Anna
    Augustynowicz, Anna
    Szajnik, Marta
    Religioni, Urszula
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)